4 May 2026Open access
Repurposing Drugs for Malaria through a Human Dose Prediction: A Case Study with BerzosertibClinical Pharmacology & Therapeutics, Malaria Research and Control
Active, last published 2026
Mathew
Njoroge
Scholar“Research profile drawn from open scholarly records.”
University of Cape Town
South Africa2
H-index
14
Citations
Mathew has not officially claimed their profile. If you are Mathew, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
01 · About the work
What I study
research summary for Mathew Njoroge will appear here once their profile is updated.
02 · Reach
Publication output and reach
Mathew's work has been cited 14 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
04 · Where I am
Affiliations
CurrentlyUniversity of Cape Town, South Africa
Research themes (UN SDGs)
05 · Selected work
Recent publications
4 works8 Apr 2026
Structure−Activity relationship and optimization of drug-like properties of antituberculosis 3-(4,4-dimethyl-1,4-azasilinane)methylpyrazole MmpL3 inhibitorsEuropean Journal of Medicinal Chemistry, Synthesis and biological activity
15 Nov 2024Open access6cites
Eliminating malaria transmission requires targeting immature and mature gametocytes through lipoidal uptake of antimalarialsNature Communications, Malaria Research and Control
14 Aug 2024Open access8cites
The Tuberculosis Drug Candidate SQ109 and Its Analogs Have Multistage Activity against <i>Plasmodium falciparum</i>ACS Infectious Diseases, Malaria Research and Control
Are you Mathew?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
No commitment required